AI Analysis AI Analysis of AMRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AMRX to Watchlist?
Some Reasons Why To Add AMRX:
  • +121.4% price growth over the last year
  • Excellent financial health (Piotroski 7/9)
  • Beat earnings estimates in 3 of the last 4 quarters
PDF

Amneal Pharmaceuticals, Inc. stock price up 0.95% on Monday
(Updated on Jul 27, 2026)

Buy or Hold candidate since Jun 03, 2026 Gain 40.45%

The Amneal Pharmaceuticals, Inc. stock price gained 0.95% on the last trading day (Monday, 27th Jul 2026), rising from $17.92 to $18.09. During the last trading day the stock fluctuated 1.65% from a day low at $17.90 to a day high of $18.19. The price has been going up and down for this period, and there has been a 5.3% gain for the last 2 weeks. Volume fell on the last day by -7 thousand shares and in total, 1 million shares were bought and sold for approximately $19.21 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 57.48% during the next 3 months and, with a 90% probability hold a price between $26.39 and $29.20 at the end of this 3-month period.

AMRX Signals & Forecast

The Amneal Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.88 and $16.79. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 21, 2026, and so far it has fallen -0.0552%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Amneal Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $17.18 and $16.34. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amneal Pharmaceuticals, Inc. finds support just below today's level at $17.18. If this is broken, then the next support from accumulated volume will be at $16.34 and $15.32.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.295 (1.65%) between high and low. For the last week, the stock has had daily average volatility of 2.78%.

Our recommended stop-loss: $17.50 (-3.26%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (AMRX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Amneal Pharmaceuticals, Inc. to open at $18.06, and during the day (based on 14 day Average True Range), to move between $17.82 and $18.36, which gives a possible trading interval of +/-$0.548 (+/-3.08%) up or down from last closing price. If Amneal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 3.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $18.10 (0.06%) than the support at $17.18 (5.03%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Amneal Pharmaceuticals, Inc. will release earnings BMO on Tuesday, August 04, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.240. We will update the financials statements for Amneal Pharmaceuticals, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 13.17% in the first trading day after earnings release.

Is Amneal Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amneal Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 3.686 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $18.06 ( 0.175%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AMRX Performance

Trading levels for AMRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 18.35 1.46%
R2 18.24 0.83%
R1 18.17 0.448%
Price 18.09
S1 17.95 -0.798%
S2 17.88 -1.18%
S3 17.76 -1.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 18.10 0.0553%
Price 18.09
S1 17.18 -5.03%
S2 16.34 -9.67%
S3 15.32 -15.31%

FAQ

What is the symbol for Amneal Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Amneal Pharmaceuticals, Inc. is AMRX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Amneal Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amneal Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy Amneal Pharmaceuticals, Inc. Stock?
Amneal Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amneal Pharmaceuticals, Inc. Stock.

What's the current price of Amneal Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 27, 2026, the price of an Amneal Pharmaceuticals, Inc. (AMRX) share was $18.09.

What is the 52-week high and low for Amneal Pharmaceuticals, Inc. Stock?
The 52-week high for Amneal Pharmaceuticals, Inc. Stock is $18.39 and the 52-week low is $7.67.

What is the market capitalization of Amneal Pharmaceuticals, Inc. Stock?
As of the Jul 27, 2026, the market capitalization of Amneal Pharmaceuticals, Inc. is 5.777B.

When is the next earnings date for Amneal Pharmaceuticals, Inc.?
The upcoming earnings date for Amneal Pharmaceuticals, Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT AMNEAL PHARMACEUTICALS, INC.
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation produc...
GOLDEN STAR
Ticker Change Signal Date
TSCO
$30.32
4.88% Jul 23
IMMR
$6.60
17.20% Jul 23
S
SW
$43.71
14.60% Jul 23
KMT
$34.39
2.70% Jul 21
DHT
$17.31
5.66% Jul 13

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE